D-Rev Brilliance Pro

D-Rev

D-Rev’s Brilliance Pro is a blue LED-based phototherapy device for treatment of neonatal jaundice with an integrated light meter, the latest model in their line of phototherapy devices.

Product description

D-Rev’s Brilliance Pro is a blue LED-based phototherapy device for treatment of neonatal jaundice with an integrated light meter, the latest model in their line of phototherapy devices.

Target region(s)

Countries Targeted: Colombia, Ecuador, Guyana, India, Kenya, Malawi, Malaysia, Myanmar, Nepal, Nigeria, Pakistan, Philippines, South Africa, Tanzania, Thailand, Uganda

Distributors/implementing organizations

Phoenix Medical Systems Private Ltd in Chennai India manufactures, distributes, and sells Brilliance under a license from D-Rev.

“D-Rev listens to customers and works with Phoenix so the product and manufacturing capabilities are aligned; it is a true partnership. The cooperation will create more products at affordable costs, and be a catalyst for market-change,” said Sashi Kumar, managing director of Phoenix Medical Systems.

Market suggested retail price

While the base retail price with 1-year warranty is marked as $400 USD, the official press release on the launch of Brilliance Pro states that the product is available at a price point of $500 USD. This may be because of a licensing agreement between D-Rev and their distributor Phoenix Medical Systems Private Ltd that caps the selling price of Brilliance products in emerging and undercapitalized markets at $400 USD. Therefore, the price may differ based on the target market.

Competitive landscape
SDG targeted
  • Goal 3: to improve and promote good health.Newborns with mild to severe jaundice. Jaundice is the #1 reason why newborns are readmitted to hospitals worldwide. About 3 in 5 children have some degree of jaundice. Severe jaundice, when left untreated or ineffectively treated, can lead to severe brain damage or death. Studies estimate that over 6 million babies with severe jaundice are not receiving adequate treatment.
Target user(s)

Hospitals and clinics with neonatal intensive care units (NICUs) or special newborn care units (SNCUs) in developing countries.

The @AutodeskFdn blogged about our how-to guide for communities writing proposals for development projects https://t.co/MlRH1H0x2F